Multicentre Italian Trials in Ovarian Cancer

Multicentre Italian Trials in Ovarian Cancer (MITO) is a leading cooperative research group based in Italy that specializes in the development and coordination of clinical trials for gynecological malignancies. The organization brings together a network of over 150 Italian oncology centers to conduct high-quality clinical research, ranging from early-phase studies to large-scale Phase III trials. MITO is a founding member of the European Network of Gynaecological Oncological Trial groups (ENGOT) and collaborates extensively with the Gynecologic Cancer InterGroup (GCIG). Their research primarily focuses on optimizing treatment strategies for ovarian, fallopian tube, and peritoneal cancers through the evaluation of novel targeted therapies, immunotherapies, and surgical techniques. By facilitating multicenter collaboration, MITO aims to improve clinical outcomes and establish new standards of care for women with gynecological cancers.